Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Email*

Password*

Keep me logged in Forgot your password?

Email*

LAMISIL TABLETS

Compare to Similar Drugs | Add to Clipboard | View Clipboard | Print | Email

Close [X]

Compare LAMISIL TABLETS to:

Generic Name for LAMISIL TABLETS

Terbinafine (as HCl) 250mg.

Legal Classification:

Pharmacological Class for LAMISIL TABLETS

Allylamine.

Manufacturer of LAMISIL TABLETS

Novartis Pharmaceuticals Corp

Indications for LAMISIL TABLETS

Onychomycosis of the toenail or fingernail due to tinea unguium.

Adult dose for LAMISIL TABLETS

≥18 years: 250mg once daily for 6 weeks (fingernail) or 12 weeks (toenail).

Children's dosing for LAMISIL TABLETS

<18 years: not recommended.

Also:

LAMISIL ORAL GRANULES

Warnings/Precautions for LAMISIL TABLETS

Onychomycosis: confirm diagnosis with nail specimen. Do baseline liver function test. Pre-existing hepatic disease or renal impairment (CrCl <50mL/min): not recommended. Discontinue if hepatobiliary dysfunction, progressive skin rash (eg, Stevens-Johnson syndrome, toxic epidermal necrolysis), or severe neutropenia occurs. Monitor CBCs if immunodeficient. Pregnancy (Cat.B), nursing mothers: not recommended.

Interactions for LAMISIL TABLETS

Potentiated by cimetidine. Antagonized by rifampin. May potentiate drugs metabolized by CYP2D6. May be potentiated by CYP2C9 and CYP3A4 inhibitors (eg, fluconazole, ketoconazole, amiodarone). Monitor cyclosporine.

Adverse Reactions for LAMISIL TABLETS

GI disturbances, liver test abnormalities, rash, pruritus, taste disturbances, urticaria; also children: nasopharyngitis, headache, pyrexia, cough, upper respiratory infection; rare: hepatotoxicity, liver failure, lupus erythematosus.

How is LAMISIL TABLETS supplied?

Tabs—30, 100; Packets—14, 42

Related Disease:

Infections, fungal~systemic antifungals

Onychomycosis~systemic antifungals

CMS Policy Helping Hospitals to Prevent Targeted Infections

May 04, 2012

Hospitals seem to be paying greater attention to preventing targeted health care-associated infections (HAIs) as a result of the Centers for Medicare and Medicaid Services (CMS) nonpayment policy.

Phase 3 Study of Vfend & Eraxis Combo Therapy for Invasive Aspergillosis

September 30, 2011

Pfizer announced results from its Phase 3 study comparing combination therapy of Vfend (voriconazole; Pfizer) and Eraxis (anidulafungin; Pfizer) to Vfend monotherapy for the treatment of invasive aspergillosis (IA).

SAFETY ALERT: Long-Term, High-Dose Diflucan May Cause Birth Defects in Pregnancy

August 03, 2011

The FDA is informing the public that chronic therapy with high-doses of Diflucan (fluconazole; Pfizer) may be associated with a rare and distinct set of birth defects in infants whose mothers were treated in the first trimester of pregnancy.

CDC updates Sexually Transmitted Diseases Treatment Guidelines

January 05, 2011

The CDC has updated its treatment guidelines for sexually transmitted diseases.

Oravig available for oropharyngeal candidiasis

August 25, 2010

Strativa has made available Oravig (miconazole buccal tablets) for the treatment of oropharyngeal candidiasis (OPC) in patients ≥16 years of age.

GRIS-PEG

Infections & Infestations > Fungal infections

Griseofulvin 125mg, 250mg; ultramicrosize; scored tabs.

LAMISIL ORAL GRANULES

Infections & Infestations > Fungal infections

Terbinafine (as HCl) 125mg, 187.5mg; per packet.

MYCAMINE

Infections & Infestations > Fungal infections

Micafungin sodium 50mg/vial, 100mg/vial; pwd for IV infusion after reconstitution and dilution; preservative-free.

NOXAFIL

Infections & Infestations > Fungal infections

Posaconazole 40mg/mL; oral susp; cherry flavor.

Updated: 12/29/2011

PENTAM 300

Infections & Infestations > Fungal infections

Pentamidine isethionate 300mg/vial; lyophilized pwd for IM or IV inj after reconstitution.

Updated: 10/5/2010

ASTELIN

Respiratory Tract > Rhinitis/rhinorrhea (intranasal products)

Adverse reactions updated.

Updated: 5/8/2012

ATRAPRO ANTIPRURITIC HYDROGEL

Dermatological Disorders > Pruritus and dry skin

Monograph added.

Updated: 4/25/2012

ATRAPRO DERMAL SPRAY

Dermatological Disorders > Pressure/neuropathic ulcers

Monograph added.

Updated: 4/24/2012

B-NEXA

Nutrition > Vitamins/minerals/supplements

Monograph added.

Updated: 4/30/2012

CETAPHIL DERMACONTROL OIL CONTROL FOAM WASH

Dermatological Disorders > Cleansers

Monograph added.

Updated: 5/10/2012

Infections & Infestations > Fungal infections

ALLYLAMINES: Allylamines (eg, terbinafine) exert their antifungal activity by interfering with fungal sterol biosynthesis at an early step through inhibition ...
more »

Treatment Update: PediPirox^™-4 Nail Kit (ciclopirox topical solution, 8%)

April 25, 2012

Update on Melanoma Treatment: SYLATRON™ (peg-interferon alfa-2b) for injection, for subcutaneous use

January 23, 2012

Acute Pain Update: SPRIX^® (ketorolac tromethamine) Nasal Spray 15.75 mg per spray

November 29, 2011

Antibiotic Formulations

April 16, 2012

Antibiotic formulation (tablets, capsules, liquids, or injection) chart.

Potentially Inappropriate Drugs for the Elderly (Beers List)

May 21, 2012

A list of drugs that may potentially be inappropriate for use in elderly patients due to their side effects. A description of the possible side effects is indicated next to each drug.

Osteoporosis Treatments

May 16, 2012

Osteoporosis treatment chart.

Mood Disorder Treatments

May 16, 2012

Mood disorder treatments for bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others.